Financing ·
Baxter International Inc. announced the pricing and early tender results for its cash tender offers of up to $600…
BAXBaxter International Inc
Baxter International Inc. announced the pricing and early tender results for its cash tender offers of up to $600 million in aggregate principal amount of outstanding senior notes, including series due 2051, 2046, 2043, and 2032. The company increased the offer cap from $500 million to $600 million and accepted all tendered notes for priority levels one through three and approximately 31.37% of level four notes on a prorated basis. Total consideration per $1,000 principal ranges from $587.34 to $867.59, including an early tender premium of $30. Settlement is scheduled for August 20, 2026. Separately, Baxter entered into Amendment No. 2 to its five-year credit agreement, increasing the maximum net leverage ratio covenant for fiscal quarters through September 2027 and removing Baxter World Trade SRL as a borrower. Baxter International Inc. operates in the healthcare industry, providing medical devices, connected solutions, and advanced injectable technologies.